• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院精神科患者超重和糖尿病的危险因素。

Risk factors for overweight and diabetes mellitus in residential psychiatric patients.

机构信息

Division of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands.

出版信息

Obes Facts. 2011;4(5):341-5. doi: 10.1159/000333420. Epub 2011 Oct 14.

DOI:10.1159/000333420
PMID:22166752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6444616/
Abstract

OBJECTIVE

To investigate the prevalence of and risk factors for overweight and diabetes mellitus in long-stay psychiatric inpatients.

METHOD

Statistical analysis of data collected from medical, laboratory, and pharmacy files.

RESULTS

80% of the 256 patients were suffering from schizophrenia or other psychotic disorders. The prevalence of diabetes mellitus was 15%. The prevalence of a disturbed glucose tolerance was 14%. Severe overweight (BMI > 30) was positively associated with the use of clozapine (odds ratio (OR) = 2.7; 95% confidence interval (CI): 1.31-5.75), but negatively with the diagnosis schizophrenia (OR = 0.4; 95% CI: 0.22-0.88). Diabetes mellitus was associated with severe overweight (OR = 3.5; 95% CI: 1.57-7.69). Caucasian patients were at a lower risk for diabetes mellitus (OR = 0.2; 95% CI: 0.08-0.54).

CONCLUSIONS

In residential psychiatric patients, diabetes mellitus is especially associated with overweight and non-Caucasian origin. In this survey, the use of clozapine was associated with overweight, but not directly with diabetes mellitus. Diabetes mellitus is highly prevalent, which calls for screening for diabetes mellitus at regular intervals.

摘要

目的

调查长期住院精神科患者超重和糖尿病的患病率及相关危险因素。

方法

对来自医疗、实验室和药房档案的数据进行统计分析。

结果

256 名患者中有 80%患有精神分裂症或其他精神障碍。糖尿病的患病率为 15%。葡萄糖耐量受损的患病率为 14%。严重超重(BMI>30)与使用氯氮平呈正相关(比值比(OR)=2.7;95%置信区间(CI):1.31-5.75),但与精神分裂症诊断呈负相关(OR=0.4;95%CI:0.22-0.88)。糖尿病与严重超重有关(OR=3.5;95%CI:1.57-7.69)。白种人患者患糖尿病的风险较低(OR=0.2;95%CI:0.08-0.54)。

结论

在住院精神科患者中,糖尿病尤其与超重和非白种人有关。在本研究中,氯氮平的使用与超重有关,但与糖尿病无直接关系。糖尿病的患病率很高,这就需要定期进行糖尿病筛查。

相似文献

1
Risk factors for overweight and diabetes mellitus in residential psychiatric patients.住院精神科患者超重和糖尿病的危险因素。
Obes Facts. 2011;4(5):341-5. doi: 10.1159/000333420. Epub 2011 Oct 14.
2
Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.接受氯氮平治疗的门诊患者中的糖尿病:患病率及临床人口统计学相关性
J Clin Psychiatry. 2005 Jul;66(7):900-6. doi: 10.4088/jcp.v66n0713.
3
The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.接受氯氮平治疗的慢性精神分裂症患者中糖尿病的患病率及其临床人口统计学相关性。
Hum Psychopharmacol. 2011 Aug;26(6):392-6. doi: 10.1002/hup.1220. Epub 2011 Aug 8.
4
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.氯氮平、糖尿病、高脂血症与心血管风险及死亡率:一项10年的自然主义研究结果
J Clin Psychiatry. 2005 Sep;66(9):1116-21. doi: 10.4088/jcp.v66n0905.
5
Clozapine and associated diabetes mellitus.氯氮平与相关的糖尿病
J Clin Psychiatry. 1997 Mar;58(3):108-11. doi: 10.4088/jcp.v58n0304.
6
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.氯氮平、糖尿病、体重增加与脂质异常:一项为期五年的自然主义研究。
Am J Psychiatry. 2000 Jun;157(6):975-81. doi: 10.1176/appi.ajp.157.6.975.
7
Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.在精神分裂症和分裂情感性障碍患者中,开始使用或换用非典型抗精神病药物治疗后的3个月内,葡萄糖代谢出现重大变化,包括新发糖尿病。
J Clin Psychiatry. 2008 Mar;69(3):472-9. doi: 10.4088/jcp.v69n0320.
8
Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.新加坡长期住院精神分裂症患者人群中糖尿病和血脂异常的患病率及其相关因素
Singapore Med J. 2018 Sep;59(9):465-471. doi: 10.11622/smedj.2018020. Epub 2018 Feb 12.
9
Clozaphobia: Is avoidance of clozapine in diabetes warranted?氯氮平恐惧症:是否有理由避免使用氯氮平治疗糖尿病?
Asian J Psychiatr. 2017 Aug;28:142-145. doi: 10.1016/j.ajp.2017.04.005. Epub 2017 Apr 14.
10
Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.与接受传统长效抗精神病药物治疗的患者相比,接受氯氮平治疗的患者中糖尿病和糖耐量受损的患病率。
J Clin Psychiatry. 1998 Jun;59(6):294-9. doi: 10.4088/jcp.v59n0604.

引用本文的文献

1
Participation and Outcomes among Disabled and Non-Disabled People in the Diabetes Pay-for-Performance Program.糖尿病绩效付费项目中残疾人和非残疾人的参与情况及结果
Healthcare (Basel). 2023 Oct 16;11(20):2742. doi: 10.3390/healthcare11202742.
2
The prevalence and clinical characteristics of diabetes mellitus in Chinese inpatients with chronic schizophrenia: a multicenter cross-sectional study.中国慢性精神分裂症住院患者中糖尿病的患病率及临床特征:一项多中心横断面研究
PeerJ. 2021 Nov 30;9:e12553. doi: 10.7717/peerj.12553. eCollection 2021.
3
A link among schizophrenia, diabetes, and asthma: Role of Ca2/cAMP signaling.精神分裂症、糖尿病和哮喘之间的联系:Ca2/cAMP信号传导的作用。
Brain Circ. 2020 Sep 30;6(3):145-151. doi: 10.4103/bc.bc_66_19. eCollection 2020 Jul-Sep.
4
Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.新加坡长期住院精神分裂症患者人群中糖尿病和血脂异常的患病率及其相关因素
Singapore Med J. 2018 Sep;59(9):465-471. doi: 10.11622/smedj.2018020. Epub 2018 Feb 12.
5
Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides.青蒿琥酯可防止大鼠出现氯氮平诱导的肝脂肪变性和血浆甘油三酯升高。
Neuropsychiatr Dis Treat. 2017 Sep 27;13:2477-2487. doi: 10.2147/NDT.S145069. eCollection 2017.

本文引用的文献

1
The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year.一组精神分裂症患者随访一年的代谢综合征发病率及其逆转情况。
J Psychiatr Res. 2009 Sep;43(13):1106-11. doi: 10.1016/j.jpsychires.2009.03.002. Epub 2009 Apr 26.
2
Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.生活方式干预与二甲双胍治疗抗精神病药物所致体重增加:一项随机对照试验。
JAMA. 2008 Jan 9;299(2):185-93. doi: 10.1001/jama.2007.56-b.
3
Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism.未服用抗精神病药物的精神分裂症患者的肝脏胰岛素抵抗:葡萄糖代谢的稳定同位素研究
J Clin Endocrinol Metab. 2008 Feb;93(2):572-7. doi: 10.1210/jc.2007-1167. Epub 2007 Nov 20.
4
Physical activity preferences and perceived barriers to activity among persons with severe mental illness in the United Kingdom.英国重症精神疾病患者的身体活动偏好及活动感知障碍
Psychiatr Serv. 2007 Mar;58(3):405-8. doi: 10.1176/ps.2007.58.3.405.
5
Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders.同时患有精神疾病和物质使用障碍的人群中糖尿病与死亡率之间的关系。
Psychiatr Serv. 2007 Feb;58(2):270-2. doi: 10.1176/ps.2007.58.2.270.
6
Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.367例使用第二代抗精神病药物治疗患者的代谢综合征与冠心病风险
J Clin Psychiatry. 2006 Apr;67(4):575-83. doi: 10.4088/jcp.v67n0408.
7
Dietary improvement in people with schizophrenia: randomised controlled trial.精神分裂症患者的饮食改善:随机对照试验。
Br J Psychiatry. 2005 Oct;187:346-51. doi: 10.1192/bjp.187.4.346.
8
Integrating physical activity into mental health services for persons with serious mental illness.将体育活动纳入严重精神疾病患者的心理健康服务中。
Psychiatr Serv. 2005 Mar;56(3):324-31. doi: 10.1176/appi.ps.56.3.324.
9
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.使用非典型抗精神病药物治疗的精神分裂症患者的葡萄糖代谢:频繁采样静脉葡萄糖耐量试验和最小模型分析
Arch Gen Psychiatry. 2005 Jan;62(1):19-28. doi: 10.1001/archpsyc.62.1.19.
10
Testing for diabetes in hospitalised patients prescribed antipsychotic drugs.对开具抗精神病药物的住院患者进行糖尿病检测。
Br J Psychiatry. 2004 Aug;185:152-6. doi: 10.1192/bjp.185.2.152.